Sparrow Pharmaceuticals
PrivateLast Round
Series B
Sep 24, 2025
Est. Valuation
$139M
Total Funding Raised
$155.2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing targeted therapies for disorders related to corticosteroid excess and cardiometabolic conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sparrow Pharmaceuticals Comparables
Compare Sparrow Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Corcept Therapeutics Incorporated | 72% | |
| Recordati SpA | 67% | |
| Crinetics Pharmaceuticals, Inc. | 67% |
Sparrow Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 24, 2025 | ||||
| Series A | Apr 12, 2024 | ||||
| Series A | May 18, 2021 |
Sparrow Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series B |
| Forbion | Series B |
| U.S. Venture Partners | Series A, Series B |
| OrbiMed | Series A, Series B |
| RiverVest Venture Partners | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 24, 2025
Zach Scheiner appointed to the Board of Directors.
- Sep 24, 2025
Nanna Lüneborg from Forbion joins the board.
Recent news
Latest coverage and updates
- hiresSep 8, 2026
Sparrow Pharma hired George Eldridge as Chief Financial Officer on Sep 8th '26.
Sparrow Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Sparrow Pharmaceuticals's valuation, stock price, and market status.
Is Sparrow Pharmaceuticals a public or private company?
Sparrow Pharmaceuticals is a private company.
What is the current stock price of Sparrow Pharmaceuticals?
Sparrow Pharmaceuticals is a private company with no public stock price. No recent secondary market data is available.
How much is Sparrow Pharmaceuticals worth (valuation)?
Valuation information for Sparrow Pharmaceuticals is not publicly available.
Can I buy Sparrow Pharmaceuticals stock?
Sparrow Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Sparrow Pharmaceuticals's last funding round?
Sparrow Pharmaceuticals's most recent funding round was Series B on September 24, 2025.
Who are the main investors in Sparrow Pharmaceuticals?
Key investors in Sparrow Pharmaceuticals include RA Capital Management, Forbion, OrbiMed.
Will Sparrow Pharmaceuticals IPO soon?
No public IPO plans have been announced for Sparrow Pharmaceuticals.
How can I track Sparrow Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sparrow Pharmaceuticals's secondary market activity and sign up for updates.